A personalized vaccine for skin cancer could cut the risk of it returning after five years. To explain this further with Claire was Orla Dolan, CEO of Breakthrough Cancer Research.
A personalized vaccine for skin cancer shows promise at clinical trial stage
A personalized vaccine for skin cancer could cut the risk of it returning after five years. To ex...
08.00 2 Jun 2026
